sq-11725 has been researched along with propranolol in 229 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 101 (44.10) | 18.7374 |
| 1990's | 35 (15.28) | 18.2507 |
| 2000's | 45 (19.65) | 29.6817 |
| 2010's | 43 (18.78) | 24.3611 |
| 2020's | 5 (2.18) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Baker, JG | 1 |
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Akamatsu, M | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Fand, RS; Hill, LS | 1 |
| Bernardi, G; Costa, G; Cremonesi, A; Guelfi, P; Mattace, R; Pagliarani, PL; Zacà, F | 1 |
| Bousser, MG; Massiou, H | 1 |
| Gordon, MS; Hollenberg, NK; Williams, GH | 1 |
| Chidambaram, B; Mehta, AV | 1 |
| Elder, CA; Restino, MS | 1 |
| Schwartz, RG; Statt, M; Welle, S | 1 |
| Allavena, A; Brambilla, G; Gazzaniga, GM; Martelli, A; Mazzei, M; Robbiano, L | 1 |
| Calès, P; Ideo, G; Lebrec, D; Pagliaro, L; Pascal, JP; Pasta, L; Poynard, T | 1 |
| Adler, LA; Angrist, B; Rotrosen, J; Weinreb, H | 1 |
| Rosen, MR; Viamonte, VA | 1 |
| Filatova, NP; Metelitsa, VI | 3 |
| Gumbatov, NB; Kasumova, FZ; Mamedova, RN; Mustafaev, II; Orudzheva, AK; Umudov, KhM | 1 |
| Cunnick, JE; Kucinski, BJ; Lysle, DT; Rabin, BS | 1 |
| Binkley, PF; Boudoulas, H; Krukemyer, JJ; Lima, JJ | 1 |
| Ol'binskaia, LI; Vartanova, OA | 1 |
| Boer, WH; DeLeve, L; Leenen, FH; Reeves, RA | 2 |
| Metelitsa, VI | 1 |
| From, RP; Mehta, MP; Pathak, D | 1 |
| Beccaria, E; Brun, S; Conti, M; Gaita, F; Giustetto, C | 1 |
| Champney, TH | 1 |
| Mihindukulasuriya, J; Waller, DG; Warren, DJ | 1 |
| Fletcher, GF | 1 |
| Brondeau, P; Cambar, J; Martin-Dupont, P | 1 |
| Allely, MC; Ungar, A | 1 |
| McDevitt, DG | 1 |
| Barradas, MA; Dandona, P; Hutton, RA; Jeremy, JY; Mikhailidis, DP; Sabur, M | 1 |
| Fishbein, L; Jackson, CD | 1 |
| Charyev, KhE; Iurenev, AP; Shkhvatsabaia, IK | 1 |
| Polakoff, S; Ratey, JJ; Sorgi, PJ | 1 |
| Epstein, M; Oster, JR | 2 |
| Burris, JF; Goldstein, J; Plachetka, JR; Sirgo, MA; Sutton, JM; Zager, PG | 1 |
| Kawada, M; Satoh, K; Taira, N | 1 |
| Tfelt-Hansen, P | 1 |
| Zawada, ET | 1 |
| Ohara, N; Reichen, J | 1 |
| Hall, PE; Kendall, MJ; Smith, SR | 1 |
| Bode, JC; Teltscher, U; Walker, S | 1 |
| Amano, H; Kubo, T; Kuwahara, M; Misu, Y | 1 |
| Harvengt, C; Heller, FR; Martiat, P; Van Nieuwenhuyze, Y | 1 |
| Bonsignore, MR; Culver, PL; Dodek, PM; Jerome, EH; Staub, NC | 1 |
| Freis, ED; Henderson, WG; Materson, BJ; Reda, D | 1 |
| Elkind, AH; Meyer, JH; Ryan, RE; Saper, JR; Stern, MA; Sudilovsky, A | 1 |
| Abiko, Y; Ichihara, K | 1 |
| Medina, JL | 1 |
| Danilo, P; Hamra, M; Rosen, MR | 1 |
| Freis, ED | 2 |
| Furberg, B; Gustavsson, CL; Olerud, B | 1 |
| Vlay, SC | 1 |
| Polakoff, SA; Ratey, JJ; Sorgi, PJ | 1 |
| Browning, MC; Feely, J; Forrest, AL; Gunn, A; Hamilton, WF; Isles, TE; Peden, NR | 1 |
| Chan, MK; Pun, KK; Yeung, CK | 1 |
| Antman, E; Ganz, P; Holman, BL; Koslowski, J; Nesto, RW; White, HD; Wynne, J | 1 |
| Coumel, P; Delhotal-Landes, B; Escoubet, B; Gourmel, B; Leclercq, JF; Maison-Blanche, P; Poirier, JM | 1 |
| From, GL; Leenen, FH; Paul, W; Reeves, RA | 1 |
| Hashimoto, H; Nakashima, M; Oguro, K; Sogabe, K; Takiguchi, Y | 1 |
| Vidt, DG | 1 |
| Weinshilboum, RM | 1 |
| El Mehairy, MM; Hamza, S; Ramadan, M; Shaker, A; Tadros, SS | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM | 1 |
| Frishman, WH; Koch-Weser, J | 1 |
| Borer, JS; Moses, JW | 1 |
| Jones, GR; Mir, MA | 1 |
| Burmeister, WE; Lee, RJ; Reynolds, RD | 1 |
| Attuel, P; Coumel, P; Leclercq, JF; Rosengarten, MD | 1 |
| Anthonisen, NR; Conliffe, TF; Fand, RS; Foley, JE; Sigurdson, MJ | 1 |
| Attuel, P; Coumel, P; Friocourt, P; Leclercq, JF | 1 |
| Iskandrian, AS; Kotler, MN; Segal, BL | 1 |
| Schiff, AA | 1 |
| Aston, EM; Kapadi, AL; Ramsden, DB; Wilkinson, R | 1 |
| Chang, MS; Chiang, BN; Lin, SL; Liu, PH; Sung, RJ; Tai, TY | 1 |
| Charyev, KhE; Erina, EV | 1 |
| Desiatnichenko, VM; Romakov, AIu; Sagirov, AM; Sobol', IuS; Sumarokov, AB | 1 |
| Feely, J; Forrest, AL; Gunn, A; Hamilton, WF; Peden, NR | 1 |
| Jackson, EA; Sullman, SA | 1 |
| Kulikova, TV; Martsevich, SIu; Metelitsa, VI; Nazarenko, VA; Nikolenko, SA | 1 |
| Lucchesi, BR; Patterson, E | 1 |
| Beaulieu, G; Grimes, D; Muirhead, C; Oshiro, G | 1 |
| Brunton, J; Danesh, BJ; Sumner, DJ | 1 |
| Crawford, MH; Miller, LA; O'Rourke, RA | 1 |
| Peele, ME; Shulkin, BL; Utiger, RD | 1 |
| Khvoĭnitskiĭ, VA; Ostapiuk, FE | 1 |
| McGoon, MD; Vlietstra, RE | 1 |
| Duchin, KL; McKinstry, DN; Stern, MA; Willard, DA | 2 |
| Attuel, P; Coumel, P; Escoubet, B | 1 |
| Sung, RJ; Svinarich, JT; Tai, DY | 1 |
| Brenner, BM; Duchin, KL; Ichikawa, I; Pfeffer, J; Pfeffer, M | 1 |
| Ryan, RE | 1 |
| Burr, WA; Wilkinson, R | 1 |
| Bouthier, J; Levenson, J; Moyse, D; Safar, ME; Simon, AC | 1 |
| Ratey, JJ; Salzman, C | 1 |
| Abed, J; Donaldson, R; Nashat, F; Taggart, P | 1 |
| Hashimoto, K; Kanazawa, Y; O'Hara, N; Ono, H | 1 |
| Anderson, S; Brater, DC; Kaplan, NM; Ram, CV | 1 |
| Hollenberg, NK | 2 |
| Kassir, S; Meltzer, HL | 1 |
| Koller, WC | 1 |
| Hess, DS; Scheinman, MM | 1 |
| Davis, D; Luderer, JR; Schneck, DW; Vary, J | 1 |
| Saxey, A; Schiff, AA | 1 |
| Belolipetskaya, VG; El'man, AR; Metelitsa, VI; Piotrovskii, VK | 1 |
| Bragina, GI; Ol'binskaia, LI | 1 |
| Frithz, G | 1 |
| Spence, JD | 1 |
| Abate, G; Brillante, C; Cerritelli, E; De Angelis, M; Di Peppe, MC; Guarino, F; Marisi, F; Polimeni, RM; Troja, C | 1 |
| Biron, P; Caillé, G; Désourdy, F; Tremblay, G | 1 |
| Jones, DR; Signore, PE | 1 |
| Beebe, HG; Messina, LM; Moursi, MM; Stanley, JC; Welling, TH | 1 |
| Cho, CH; Yat, PC | 1 |
| Agostoni, E; Zocchi, L | 1 |
| Berul, CI; Dubin, AM; Shah, MJ; Sweeten, TL; Vetter, VL | 1 |
| Campanati, L; Di Mauro, P; Gridelli, B; Langer, M; Peta, M; Pezzi, A; Pifferi, S; Prato, P; Proietti, D; Quarenghi, E | 1 |
| Abe, K; Fujiwara, I; Igarashi, Y; Inoue, CN; Ito, O; Kondo, Y; Kudo, K; Takahashi, N | 1 |
| Conn, CA; Kluger, MJ; Kozak, W; Rudolph, K; Soszynski, D | 1 |
| Pruett, SB; Wu, WJ | 1 |
| Heinemann, A; Krejs, GJ; Stauber, RE; Trauner, M | 1 |
| Bochnowicz, S; Matthews, JK; Osborn, RR; Torphy, TJ; Underwood, DC | 1 |
| Bayer, BM; Dretchen, KL; Flores, LR | 1 |
| Kleven, MS; Koek, W | 1 |
| Sachdev, PS; Saharov, T | 1 |
| Ben-Eliyahu, S; Shakhar, G | 1 |
| Cahill, L; Everaerd, W; Gooren, LJ; McGaugh, JL; van Stegeren, AH | 1 |
| Cho, CH; Kaan, SK | 1 |
| Cahill, L; Drysdale, E; Ebmeier, KP; O'Carroll, RE; Shajahan, P | 1 |
| Chaturvedi, S; Chugani, DC; Chugani, HT; Fakhouri, M; Lee, ML; Muzik, O; Niimura, K | 1 |
| Belhassen, B; Dorostkar, PC; Eldar, M; Scheinman, MM | 1 |
| Andrews, ML; Benhorin, J; Crampton, RS; Hall, WJ; Locati, EH; Medina, A; Moss, AJ; Napolitano, C; Priori, SG; Robinson, JL; Schwartz, PJ; Timothy, K; Towbin, JA; Vincent, GM; Zareba, W; Zhang, L | 1 |
| Bosch, J | 1 |
| Blaak, EE; Saris, WH; Schiffelers, SL; van Baak, MA | 1 |
| Assi, SA; Sanyal, A; Schubert, ML | 1 |
| Hirvonen, J; Jaskari, T; Kontturi, K; Manzanares, JA; Vuorio, M | 1 |
| Horinouchi, T; Koike, K | 1 |
| De Smet, M; Goldberg, MR; Halpin, R; James, I; Kari, PH; Lee, Y; Lowry, R; Olah, TV; Sciberras, D; Tomasko, L; Vyas, KP; Zhao, J | 1 |
| Hirvonen, J; Laukkanen, A; Tenhu, H; Vihola, H | 1 |
| Flevari, P; Kremastinos, DT; Livanis, EG; Mesiskli, T; Theodorakis, GN; Zarvalis, E | 1 |
| Kobayashi, S; Kondo, H; Takahashi, Y; Watanabe, T; Yasuda, T; Yokohama, S | 1 |
| Krist, A; Phillips, J | 1 |
| Beversdorf, DQ; Bornstein, RA; Chever, DC; Hughes, JD; White, DM | 1 |
| Foran, CM; Huggett, DB; Khan, IA; Schlenk, D | 1 |
| Cain, DP; Saber, AJ | 1 |
| Andersson, KK; Barra, AL; Engalytcheff, A; Kolberg, M; Tilquin, B | 1 |
| Bloise, R; Chiaretti, A; De Rosa, G; Delogu, AB; Piastra, M; Priori, SG | 1 |
| Bhaskar, ME | 1 |
| Abbott, A | 1 |
| Beigi, F; Chakir, K; Wainer, IW; Xiao, RP | 1 |
| Fu, XC; Sun, Q | 1 |
| Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M | 1 |
| Balimane, P; Kadiyala, P; Olah, T; Smalley, J; Xin, B | 1 |
| Laleman, W; Nevens, F | 1 |
| Bilodeau, ML; Hamm, HE; Holinstat, M; Voss, B | 1 |
| Leira, R; Pascual, J; Rivas, MT | 1 |
| Franklin, KB; Robinson, MJ | 1 |
| Chen, L; Kibbey, TC; Paruchuri, R; Sabatini, DA | 1 |
| De Martino, B; Dolan, RJ; Strange, BA | 1 |
| Cortez, V; Fleshner, M; Foley, TE; Hanson, H; Johnson, JD; Kennedy, SL | 1 |
| Buszewski, B; Krzemiński, TF; Tegowska, E; Welerowicz, T | 1 |
| Connor, TJ; Curtin, NM; Mills, KH | 1 |
| Alvarez-Urturi, C; Aracil, C; Balanzó, J; Colomo, A; Guarner, C; Hernández-Gea, V; López-Balaguer, JM; Torras, X; Villanueva, C | 1 |
| Shimizu, T | 1 |
| Akhavan, MM; Ebrahimi, S; Rashidy-Pour, A; Vafaei, AA | 1 |
| Abduljalil, A; Beversdorf, DQ; Carpenter, AL; Narayanan, A; Saklayen, S; Scaduto, MJ; Schmalbrock, P; White, CA | 1 |
| Gilpin, NW; Koob, GF | 1 |
| Abraldes, JG; Berzigotti, A; Bosch, J; Garcia-Pagan, JC; Saez, R; Tandon, P | 1 |
| Bond, RA; Dickey, BF; Franklin, AE; Garner, WJ; Hanania, NA; Lipworth, BJ; Mannava, B; Williamson, PA | 1 |
| Patel, DK; Shrivas, K | 1 |
| Cohen, H; Geva, AB; Kaplan, Z; Koresh, O; Matar, MA; Zohar, J | 1 |
| Massarsky, A; Moon, TW; Trudeau, VL | 1 |
| Talwalkar, JA | 1 |
| Schwartz, PJ | 1 |
| Besana, A; George, AL; Schwartz, PJ; Wang, DW | 1 |
| Choe, WH; Kim, JH; Ko, SY; Kwon, SY; Lee, CH | 1 |
| Camp, RM; Johnson, JD; Kalburgi, SN; Porterfield, VM; Remus, JL | 1 |
| Chakkittakandiyil, A; Lara-Corrales, I; Maki, E; Pope, E; Weinstein, M | 1 |
| Figueroa, JJ; Fischer, PR; Gehrking, JA; Iodice, V; Kimpinski, K; Low, PA; Opfer-Gehrking, TL; Sandroni, P; Singer, W; Sletten, DM | 1 |
| Daubert, JP; Grant, AO; Nilsson, KR | 1 |
| Ackerman, MJ; Beckmann, BM; Blom, NA; Chockalingam, P; Clur, SA; Crotti, L; Fischer, M; Girardengo, G; Harris, KM; Hauer, RN; Johnson, JN; Kääb, S; Rordorf, R; Rydberg, A; Schwartz, PJ; Spazzolini, C; van den Heuvel, F; van der Heijden, JF; Wilde, AA | 1 |
| Bai, M; Fan, D; Han, G; Qi, X; Yang, M | 1 |
| Abu-Zeitone, A; McNitt, S; Moss, AJ; Peterson, DR; Polonsky, B | 1 |
| Bautista-Paloma, FJ; Cotrina-Luque, J; Del Vayo-Benito, CA; Flores-Moreno, S; Villalba-Moreno, AM | 1 |
| Ackerman, MJ; Bos, JM; Cannon, BC; Poterucha, JT | 1 |
| Bond, RA; Bouvier, M; Forkuo, GS; Joshi, R; Knoll, BJ; Leff, P; Parra, S; Thanawala, VJ; Valdez, DJ | 1 |
| Everitt, BJ; Milton, AL; Schramm, MJ | 1 |
| Fruge, JH; Massengale, WT; Rouhana, HF | 1 |
| Lishmanov, YB; Maslov, LN; Mukhomedzyanov, AV | 1 |
| Advani, S; Cao, Y; El-Serag, HB; Kanwal, F; Kramer, J; Shukla, R; Tansel, A; Walder, A; Ying, J | 1 |
| Beversdorf, DQ; Christ, SE; Ferguson, BJ; Hegarty, JP; Johnson, JD; Rohowetz, LJ; Zamzow, RM | 1 |
| Gamelli, RL; Hasan, S; Mosier, MJ; Muthumalaiappan, K; Szilagyi, A | 1 |
| Hayes, P; Robertson, M | 1 |
| Cogan, ES; Robinson, TE; Shapses, MA; Tronson, NC | 1 |
| Bendtsen, F; Gluud, LL; Hobolth, L; Jeyaraj, R; Morgan, MY; Zacharias, AP | 1 |
| Atrooz, F; Bond, RA; Kochi, C; Liu, H; Salim, S; Valdez, D; Zaidi, S | 1 |
| Driessen, RJB; Logger, JGM; Olydam, JI | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Cushing, SL; Pope, E; Propst, EJ; Wolter, JK; Wolter, NE; Yang, W | 1 |
| Drolet, B; Kanigsberg, N; Lara-Corrales, I; Liy-Wong, C; Ma, J; Pope, E; Sibbald, C | 1 |
26 review(s) available for sq-11725 and propranolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propranolol | 1992 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol | 1991 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta blockers and renal function: a reappraisal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Urea Nitrogen; Cardiac Output; Creatinine; Dogs; Glomerular Filtration Rate; Heart; Humans; Hypertension; Kidney; Labetalol; Metoprolol; Nadolol; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance | 1985 |
Pharmacological therapy of portal hypertension.
Topics: Acute Disease; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hypertension, Portal; Nadolol; Propranolol; Somatostatin; Vasopressins | 1986 |
Ethnics differences in the reactions to drugs and xenobiotics. Antihypertensive agents.
Topics: Antihypertensive Agents; Bendroflumethiazide; Black People; Clinical Trials as Topic; Diuresis; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Nadolol; Natriuresis; Propanolamines; Propranolol; Renin; White People | 1986 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Biological Availability; Cardiac Output; Depression, Chemical; Heart Rate; Humans; Hypertension; Kidney; Metabolism; Methyldopa; Myocardial Contraction; Nadolol; Oxygen Consumption; Propanolamines; Propranolol; Regional Blood Flow; Renin; Respiration; Vascular Resistance | 1980 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Metoprolol; Migraine Disorders; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1981 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
Beta-blockers and the kidney.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Cardiac Output; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Nadolol; Physical Exertion; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance | 1982 |
Beta-adrenoceptor blockade and anaesthesia for thyroidectomy.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Blood Glucose; Drug Therapy, Combination; Hormones; Humans; Nadolol; Potassium Iodide; Premedication; Propanolamines; Propranolol; Thyroid Crisis; Thyroidectomy; Time Factors | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; Metoprolol; Migraine Disorders; Myocardial Infarction; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
The kidney and strategies for the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Nadolol; Natriuresis; Propanolamines; Propranolol; Renal Circulation; Renin-Angiotensin System; Teprotide; Vasodilator Agents | 1984 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half-Life; Humans; Hypertension; Lidocaine; Metoprolol; Nadolol; Nifedipine; Propanolamines; Propranolol; Tocainide; Verapamil | 1983 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
[Beta blockers in migraine prophylaxis].
Topics: Adrenergic beta-Antagonists; Drug Administration Schedule; Humans; Metoprolol; Migraine Disorders; Nadolol; Premedication; Propranolol | 2009 |
β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Endocrine Disruptors; Fishes; Gluconeogenesis; Glucose; Glycogenolysis; Insulin; Insulin Secretion; Lipolysis; Metoprolol; Molecular Structure; Mollusca; Muscle Contraction; Nadolol; Propranolol; Species Specificity; Water Pollutants, Chemical | 2011 |
Pharmacotherapy alone vs endoscopic variceal ligation combination for secondary prevention of oesophageal variceal bleeding: meta-analysis.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Ligation; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2012 |
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
Topics: Combined Modality Therapy; Databases, Bibliographic; Drug Therapy, Combination; Endpoint Determination; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Isosorbide Dinitrate; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Spironolactone | 2014 |
Beta blocker treatment for infantile hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2015 |
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Topics: Adrenergic beta-Antagonists; Adult; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Randomized Controlled Trials as Topic; Secondary Prevention | 2018 |
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Drug Evaluation; Erythema; Facial Dermatoses; Flushing; Humans; Hypotension; Nadolol; Propranolol; Retrospective Studies; Rosacea; Treatment Outcome | 2020 |
50 trial(s) available for sq-11725 and propranolol
| Article | Year |
|---|---|
A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Antihypertensive Agents; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Placebos; Propanolamines; Propranolol | 1979 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Nadolol; Propranolol; Prospective Studies; Tachycardia, Supraventricular; Treatment Outcome | 1992 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol | 1991 |
[The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New P
Topics: Adult; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Prazosin; Propranolol; Remission Induction; Time Factors; USSR | 1991 |
The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Pr
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Patient Dropouts; Prazosin; Propranolol; Remission Induction; Time Factors; USSR | 1991 |
[State of the hypophyseal-gonadal system in patients with hypertension during long-term treatment with nadolol and anaprilin].
Topics: Adult; Estradiol; Follicle Stimulating Hormone; Humans; Hypertension; Luteinizing Hormone; Male; Middle Aged; Nadolol; Pituitary Gland; Prolactin; Propranolol; Radioimmunoassay; Testis; Testosterone; Time Factors | 1991 |
[Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].
Topics: Adult; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Nadolol; Prazosin; Propranolol; Time Factors | 1990 |
Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
Topics: Adult; Blood Pressure; Half-Life; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Propranolol; Pulse; Substance Withdrawal Syndrome | 1990 |
Beta-blockade disappearance rate predicts beta-adrenergic hypersensitivity.
Topics: Adult; Clinical Trials as Topic; Hemodynamics; Humans; Isoproterenol; Male; Nadolol; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Substance Withdrawal Syndrome | 1989 |
[The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension].
Topics: Adult; Blood Pressure; Electrocardiography; Glucose Tolerance Test; Heart Rate; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Nadolol; Propranolol; Respiration; Time Factors; USSR | 1989 |
Beta-blockers and psychometric performance: studies in normal volunteers.
Topics: Adrenergic beta-Antagonists; Atenolol; Diazepam; Dose-Response Relationship, Drug; Humans; Lipid Metabolism; Nadolol; Oxazepam; Propanolamines; Propranolol; Psychometrics; Psychomotor Performance; Random Allocation; Reaction Time; Reference Values; Solubility; Time Factors | 1985 |
The effect of non-specific beta-blockade on metabolic and haemostatic variables during hypoglycaemia.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Platelets; Blood Pressure; Factor VIII; Fatty Acids, Nonesterified; Female; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Nadolol; Platelet Aggregation; Potassium; Propanolamines; Propranolol; Pulse; Thromboxane B2 | 1985 |
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propranolol | 1986 |
Efficacy of beta-blockers in migraine. A critical review.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Migraine Disorders; Nadolol; Propranolol; Racemases and Epimerases; Timolol | 1986 |
Renal hemodynamic changes after beta-blocker-diuretic combination therapy in azotemic hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Nadolol; Propranolol; Random Allocation; Renal Circulation; Uremia | 1986 |
The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate.
Topics: Adrenergic beta-Antagonists; Adult; Ammonia; Female; Heart Rate; Humans; Male; Metoprolol; Nadolol; Physical Exertion; Pindolol; Propranolol | 1987 |
[Beta-receptor blockaders in the prevention of hemorrhaging of esophageal varices?].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Drug Evaluation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Metoprolol; Nadolol; Placebos; Propranolol; Sclerosing Solutions | 1987 |
Cigarette smoking interferes with treatment of hypertension.
Topics: Adult; Bendroflumethiazide; Black People; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Propranolol; Random Allocation; Retrospective Studies; Smoking; White People | 1988 |
Comparative efficacy of nadolol and propranolol in the management of migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propranolol; Random Allocation | 1987 |
Ethnics differences in the reactions to drugs and xenobiotics. Antihypertensive agents.
Topics: Antihypertensive Agents; Bendroflumethiazide; Black People; Clinical Trials as Topic; Diuresis; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Nadolol; Natriuresis; Propanolamines; Propranolol; Renin; White People | 1986 |
Nadolol and propranolol in migraine management.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propranolol; Random Allocation | 1986 |
Comparison of four beta-blockers as assessed by 24-hour ECG recording.
Topics: Acebutolol; Administration, Oral; Adult; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Nadolol; Propanolamines; Propranolol; Random Allocation | 1986 |
Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol.
Topics: Adult; Cell Membrane; Heart Rate; Humans; Male; Nadolol; Propanolamines; Propranolol; Random Allocation; Resins, Plant; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse | 1985 |
Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1980 |
Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Humans; Middle Aged; Nadolol; Nitroglycerin; Oxprenolol; Physical Exertion; Propanolamines; Propranolol | 1981 |
[Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Echocardiography; Heart; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
[Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nadolol; Physical Exertion; Placebos; Propanolamines; Propranolol | 1984 |
Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Nadolol; Propanolamines; Propranolol; Pulse; Random Allocation; Renal Circulation; Vascular Resistance | 1984 |
[Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Coronary Disease; Humans; Hypertension; Middle Aged; Myocardial Infarction; Nadolol; Propanolamines; Propranolol; Recurrence | 1984 |
Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cimetidine; Drug Interactions; Half-Life; Heart Rate; Humans; Kinetics; Male; Nadolol; Propanolamines; Propranolol | 1984 |
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Oxprenolol; Propanolamines; Propranolol; Random Allocation; Renin; United States; United States Department of Veterans Affairs | 1984 |
Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propanolamines; Propranolol; Random Allocation | 1984 |
A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Creatinine; Female; Heart Rate; Humans; Hyperthyroidism; Kinetics; Male; Middle Aged; Nadolol; Patient Compliance; Posture; Propanolamines; Propranolol; Random Allocation; Thyroid Hormones; Time Factors | 1984 |
Nadolol in essential tremor.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Nadolol; Placebos; Propanolamines; Propranolol; Tremor | 1983 |
Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1982 |
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation?
Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Monitoring, Intraoperative; Nadolol; Oxygen; Propranolol; Risk Factors | 1994 |
Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Double-Blind Method; Emotions; Female; Heart Rate; Humans; Male; Memory; Nadolol; Neuropsychological Tests; Propranolol; Receptors, Adrenergic, beta | 1998 |
Memory for emotional material: a comparison of central versus peripheral beta blockade.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Blood-Brain Barrier; Central Nervous System; Emotions; Female; Heart Rate; Humans; Male; Memory; Memory, Short-Term; Nadolol; Peripheral Nervous System; Propranolol; Stress, Psychological | 1999 |
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Female; Humans; Infant; Long QT Syndrome; Male; Metoprolol; Nadolol; Propranolol; Survival Analysis | 2000 |
In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Body Temperature Regulation; Calorimetry, Indirect; Dose-Response Relationship, Drug; Hemodynamics; Humans; Isoproterenol; Lipids; Male; Nadolol; Propranolol; Receptors, Adrenergic, beta; Reference Values; Respiration; Single-Blind Method | 2000 |
Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Biological Availability; Cardiovascular System; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; In Vitro Techniques; Male; Metoprolol; Middle Aged; Nadolol; Propranolol; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2001 |
Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
Topics: Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Nadolol; Propranolol; Prospective Studies; Recurrence; Syncope, Vasovagal; Treatment Outcome | 2002 |
Beta-blockers no better than placebo in the treatment of vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nadolol; Probability; Prognosis; Propranolol; Prospective Studies; Reference Values; Severity of Illness Index; Syncope, Vasovagal; Treatment Outcome | 2002 |
Central beta-adrenergic modulation of cognitive flexibility.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cognition; Ephedrine; Female; Humans; Male; Nadolol; Norepinephrine; Problem Solving; Propranolol; Receptors, Adrenergic, beta | 2002 |
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2005 |
Testing the combination beta-blocker plus topiramate in refractory migraine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Propranolol; Topiramate; Treatment Outcome | 2007 |
Noradrenergic neuromodulation of human attention for emotional and neutral stimuli.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Arousal; Attention; Attentional Blink; Brain; Color Perception; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Female; Humans; Male; Morpholines; Nadolol; Norepinephrine; Pattern Recognition, Visual; Propranolol; Reboxetine; Semantics | 2008 |
Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Portal Pressure; Predictive Value of Tests; Proportional Hazards Models; Propranolol; Risk Assessment; ROC Curve; Time Factors; Treatment Outcome | 2009 |
Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Double-Blind Method; Equivalence Trials as Topic; Female; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Neoplastic Syndromes, Hereditary; Ontario; Propranolol; Prospective Studies; Treatment Outcome | 2022 |
156 other study(ies) available for sq-11725 and propranolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Comparative study of the anti-angina effectiveness of nadolol and propranolol].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1979 |
Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade.
Topics: Adrenal Glands; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Infusion Pumps; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Nadolol; Posture; Propranolol | 1992 |
Reduced metabolic rate during beta-adrenergic blockade in humans.
Topics: Adult; Analysis of Variance; Basal Metabolism; Blood Pressure; Body Weight; Humans; Male; Nadolol; Propranolol; Pulse; Receptors, Adrenergic, beta; Thyroxine; Triiodothyronine | 1991 |
Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Survival; DNA; DNA Damage; DNA Repair; Humans; Liver; Male; Metoprolol; Nadolol; Nitrosamines; Nitrosation; Oxprenolol; Propranolol; Rats; Rats, Inbred Strains; Sodium Nitrite; Sotalol | 1991 |
Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Nadolol; Parkinson Disease; Propranolol; Psychomotor Agitation; Time Factors | 1991 |
Premature escape beats induced by overdrive pacing in canine Purkinje fibers. Evidence for the role of normal automaticity as an underlying cellular mechanism.
Topics: Animals; Anti-Arrhythmia Agents; Biomechanical Phenomena; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Dogs; Doxorubicin; Heart Conduction System; Lidocaine; Moricizine; Nadolol; Phenothiazines; Propranolol; Purkinje Fibers | 1990 |
Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Animals; Corticosterone; Electroshock; Immune Tolerance; Leukocyte Count; Lymphocyte Activation; Male; Nadolol; Propranolol; Rats; Rats, Inbred Lew; Receptors, Adrenergic, beta; Spleen; Stress, Physiological | 1990 |
[Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Cardiac Complexes, Premature; Coronary Disease; Female; Heart; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1986 |
[Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Metoprolol; Nadolol; Nifedipine; Nitrates; Nitroglycerin; Propranolol; Verapamil | 1989 |
Serum potassium concentrations following succinylcholine in patients undergoing beta-adrenoceptor blocking therapy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Heart Rate; Humans; Metoprolol; Middle Aged; Nadolol; Ophthalmic Solutions; Potassium; Propranolol; Succinylcholine; Time Factors; Timolol | 1989 |
[Torsade de pointes during an atropine sulfate test in a patient with congenital long QT syndrome].
Topics: Arrhythmias, Cardiac; Atropine; Cardiac Pacing, Artificial; Humans; Long QT Syndrome; Male; Middle Aged; Nadolol; Propranolol; Tachycardia | 1989 |
Beta-adrenergic blockers prevent short photoperiod-induced gonadal regression, but not melatonin-induced regression in male Syrian hamsters.
Topics: Animals; Cricetinae; Male; Melatonin; Mesocricetus; Nadolol; Organ Size; Periodicity; Pineal Gland; Propranolol; Testis; Testosterone | 1989 |
A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Heart Rate; Humans; Infusions, Parenteral; Inulin; Kidney; Male; Nadolol; p-Aminohippuric Acid; Propanolamines; Propranolol; Saline Solution, Hypertonic; Sodium | 1985 |
Exercise training during chronic beta blockade in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Artery Bypass; Female; Heart Rate; Humans; Male; Metoprolol; Myocardial Infarction; Nadolol; Physical Exertion; Propanolamines; Propranolol; Timolol | 1985 |
[Influence of 3 beta-blockers on the diameter of glomeruli isolated from the renal cortex of rats].
Topics: Adrenergic beta-Antagonists; Animals; Kidney Cortex; Kidney Glomerulus; Male; Nadolol; Propanolamines; Propranolol; Rats; Thiophenes; Verapamil | 1985 |
Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
Topics: Adrenergic beta-Antagonists; Animals; Carbimazole; Dogs; Drug Interactions; Electrocardiography; Heart Conduction System; Heart Rate; Isoproterenol; Male; Nadolol; Propanolamines; Propranolol; Sotalol; Thyroid Hormones; Triiodothyronine | 1985 |
[Regression of left-ventricular myocardial hypertrophy in patients with hypertension during long-term treatment with beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Time Factors | 1986 |
Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Chronic Disease; Female; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Schizophrenia, Paranoid | 1986 |
Cardiohemodynamic effects of nipradilol (K-351) in the dog: comparison with propranolol, nadolol and prazosin.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Male; Nadolol; Prazosin; Propanolamines; Propranolol | 1986 |
Beta-adrenergic blockers for aggressive behavior in schizophrenia.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Nadolol; Propranolol; Schizophrenia; Schizophrenic Psychology | 1987 |
A trial for kinetic evaluation of the antagonistic potency of several beta-antagonists on presynaptic beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Kinetics; Male; Nadolol; Norepinephrine; Pindolol; Propranolol; Pulmonary Artery; Receptors, Adrenergic, beta | 1987 |
Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Apolipoproteins; Atenolol; Humans; Lipids; Lipoprotein Lipase; Lipoproteins; Liver; Male; Nadolol; Pindolol; Propranolol | 1987 |
Effects of beta-adrenergic agents in lungs of normal and air-embolized awake sheep.
Topics: Adrenergic beta-Agonists; Animals; Atenolol; Blood Pressure; Blood Proteins; Cardiac Output; Embolism, Air; Female; Lung; Lymph; Nadolol; Propranolol; Proteins; Pulmonary Circulation; Reference Values; Sheep | 1988 |
Cardiac metabolism as an indicator of oxygen supply/demand ratio.
Topics: Animals; Calcium Channel Blockers; Carteolol; Dogs; Female; Fructosediphosphates; Fructosephosphates; Glucose-6-Phosphate; Glucosephosphates; Heart; In Vitro Techniques; Male; Myocardium; Nadolol; Oxygen Consumption; Propranolol | 1988 |
Effectiveness of nadolol in a clinic population of migrainous patients.
Topics: Adolescent; Adult; Antidepressive Agents; Female; Humans; Male; Middle Aged; Migraine Disorders; Muscle Contraction; Nadolol; Propranolol; Prospective Studies | 1988 |
Developmental changes in the effects of nadolol on adult and neonatal canine Purkinje fibers.
Topics: Action Potentials; Aging; Animals; Animals, Newborn; Dogs; Heart Conduction System; In Vitro Techniques; Membrane Potentials; Nadolol; Propranolol; Purkinje Fibers; Solubility | 1988 |
Catecholamine-sensitive ventricular tachycardia.
Topics: Adult; Arrhythmias, Cardiac; Catecholamines; Female; Heart Ventricles; Humans; Isoproterenol; Male; Nadolol; Physical Exertion; Propranolol | 1987 |
The treatment of impulsive and aggressive behavior with nadolol.
Topics: Adult; Aggression; Humans; Impulsive Behavior; Intellectual Disability; Male; Nadolol; Propanolamines; Propranolol | 1986 |
The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens.
Topics: Adult; Body Temperature; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; Nadolol; Potassium Iodide; Premedication; Propanolamines; Propranolol; Pulse; Time Factors | 1985 |
Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.
Topics: Adult; Aged; beta 2-Microglobulin; Blood Pressure; Creatinine; Female; Heart Rate; Humans; Hypertension, Renal; Kidney; Kidney Function Tests; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1985 |
Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Isosorbide; Male; Metoprolol; Middle Aged; Nadolol; Nifedipine; Nitroglycerin; Physical Exertion; Propanolamines; Propranolol; Radionuclide Imaging; Rest | 1985 |
Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
Topics: Alprenolol; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epinephrine; Female; Halothane; Male; Nadolol; Ouabain; Propanolamines; Propranolol | 1985 |
Antihypertensive drugs that alter adrenergic function.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Catecholamines; Central Nervous System; Clonidine; Guanethidine; Humans; Methyldopa; Metoprolol; Nadolol; Prazosin; Propanolamines; Propranolol; Receptors, Adrenergic; Reserpine; Sympathetic Nervous System | 1980 |
Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dogs; Female; Heart; Heart Rate; Male; Membranes; Myocardial Infarction; Nadolol; Propanolamines; Propranolol | 1981 |
Role of sympathetic nervous system in non-ischaemic ventricular arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Child; Electrocardiography; Exercise Test; Female; Heart Ventricles; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Sympathetic Nervous System | 1982 |
Effects of cardioselective and nonselective beta-adrenergic antagonists on pulmonary mechanics.
Topics: Adrenergic beta-Antagonists; Adult; Humans; Lung; Lung Volume Measurements; Male; Metoprolol; Nadolol; Organ Specificity; Propanolamines; Propranolol; Pulmonary Ventilation | 1982 |
[Atrial arrhythmias of vagal or catecholaminergic origin: comparative effects of beta-blocker treatment and the escape phenomenon].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Catecholamines; Diagnosis, Differential; Drug Resistance; Drug Therapy, Combination; Female; Heart; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Vagus Nerve | 1982 |
Managing angina with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Humans; Metoprolol; Nadolol; Nitrates; Propanolamines; Propranolol; Timolol | 1982 |
Nadolol instead of propranolol?
Topics: Adrenergic beta-Antagonists; Hallucinations; Humans; Nadolol; Propanolamines; Propranolol; Sleep Initiation and Maintenance Disorders | 1983 |
The effect of beta-blockade therapy on serum thyroxine binding globulin (TBG) concentration.
Topics: Adrenergic beta-Antagonists; Female; Humans; Hyperthyroidism; Male; Nadolol; Propanolamines; Propranolol; Thyroxine-Binding Proteins | 1983 |
Nadolol and supraventricular tachycardia: an electrophysiologic study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Catheterization; Drug Evaluation; Electrocardiography; Female; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Recurrence; Tachycardia, Paroxysmal | 1983 |
[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Echocardiography; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Dose-Response Relationship, Drug; Heart Conduction System; Male; Nadolol; Propanolamines; Propranolol; Sotalol; Ventricular Fibrillation | 1984 |
Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Topics: Acetamides; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Cats; Coronary Circulation; Dogs; Hemodynamics; Isoproterenol; Macaca mulatta; Membranes; Myocardium; Nadolol; Organ Specificity; Oxygen Consumption; Pindolol; Propanolamines; Propranolol; Stroke Volume; Vascular Resistance | 1984 |
Nadolol compared to propranolol for treating chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Nadolol; Physical Exertion; Propanolamines; Propranolol; Random Allocation | 1984 |
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dithiothreitol; Liver; Male; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Timolol; Triiodothyronine | 1984 |
Beta-adrenergic blockers. Choosing among them.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Tachycardia; Time Factors | 1984 |
Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiology; Heart Conduction System; Humans; Nadolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tachycardia; Tachycardia, Paroxysmal | 1984 |
Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Heart Failure; Heart Rate; Male; Myocardial Infarction; Nadolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Renal Circulation; Vascular Resistance | 1984 |
Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Forearm; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Regional Blood Flow; Time Factors; Vascular Resistance | 1984 |
Recognizing and managing akathisia.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Nadolol; Propanolamines; Propranolol; Schizophrenia | 1984 |
Class III action of beta-blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol | 1984 |
Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Anti-Arrhythmia Agents; Dogs; Heart; Heart Rate; In Vitro Techniques; Myocardial Contraction; Nadolol; Papillary Muscles; Pindolol; Propanolamines; Propranolol | 1984 |
Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Male; Nadolol; Propanolamines; Propranolol; Renin | 1984 |
Inhibition of calmodulin-activated Ca2+-ATPase by propranolol and nadolol.
Topics: Binding, Competitive; Calcium-Binding Proteins; Calcium-Transporting ATPases; Calmodulin; Enzyme Activation; Humans; In Vitro Techniques; Kinetics; Membranes; Nadolol; Propanolamines; Propranolol | 1983 |
Effects of nadolol and propranolol on plasma lidocaine clearance.
Topics: Adult; Drug Interactions; Female; Heart Rate; Humans; Infusions, Parenteral; Lidocaine; Liver; Male; Nadolol; Propanolamines; Propranolol | 1984 |
Autoradiography of nadolol and propranolol in the rat.
Topics: Animals; Autoradiography; Brain; Central Nervous System; Female; Male; Nadolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Tissue Distribution | 1984 |
Ion-exchange high-performance liquid chromatography in drug assay in biological fluids. III. Propranolol, nadolol and prazosin.
Topics: Chromatography, High Pressure Liquid; Humans; Nadolol; Prazosin; Propanolamines; Propranolol; Quinazolines; Saliva | 1983 |
Nonselective beta-blockade enhances pressor responsiveness to epinephrine, norepinephrine, and angiotensin II in normal man.
Topics: Adult; Angiotensin II; Blood Pressure; Body Weight; Drug Interactions; Epinephrine; Heart Rate; Humans; Infusions, Parenteral; Male; Nadolol; Norepinephrine; Physical Exertion; Propanolamines; Propranolol; Random Allocation; Sodium | 1984 |
Kinetic interactions of nadolol and propranolol with cimetidine.
Topics: Adolescent; Adult; Cimetidine; Drug Interactions; Humans; Kinetics; Male; Nadolol; Propanolamines; Propranolol | 1984 |
[Clinical, cardio- and hemodynamic effects of long- and short-acting beta-adrenergic blockers in the treatment of patients with stable stenocardia].
Topics: Adult; Aged; Angina Pectoris; Exercise Test; Female; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Myocardial Contraction; Nadolol; Pindolol; Propanolamines; Propranolol | 1984 |
Effects of antihypertensive agents on blood velocity: implications for atherogenesis.
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Placebos; Propanolamines; Propranolol; Ultrasonography | 1982 |
[Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
Topics: Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1982 |
Nadolol dosage after propranolol.
Topics: Angina Pectoris; Humans; Nadolol; Propanolamines; Propranolol | 1982 |
Effect of pharmacological blockade on cardiovascular responses to voluntary and forced diving in muskrats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arvicolinae; Atropine; Cardiovascular Physiological Phenomena; Cardiovascular System; Diving; Female; Heart Rate; Male; Muscarinic Antagonists; Nadolol; Phentolamine; Propranolol | 1995 |
Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity.
Topics: Animals; Aorta, Thoracic; Aortic Aneurysm; Atenolol; Blood Pressure; Heart Rate; Male; Mice; Mice, Mutant Strains; Nadolol; Propranolol; Protein-Lysine 6-Oxidase | 1995 |
Effects of beta-adrenoceptor antagonists on portal vein hypertension and ethanol-induced gastric mucosal damage in rats.
Topics: Adrenergic beta-Antagonists; Animals; Ethanol; Gastric Mucosa; Hemodynamics; Hypertension, Portal; Labetalol; Male; Metoprolol; Nadolol; Pindolol; Propranolol; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1994 |
Effects of beta-adrenergic blockade or stimulation on net rate of hydrothorax absorption.
Topics: Absorption; Animals; Hydrothorax; Lymphatic System; Muscle, Smooth; Nadolol; Pleura; Propranolol; Proteins; Rabbits; Receptors, Adrenergic, beta; Terbutaline | 1994 |
Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children.
Topics: Adolescent; Adult; Bundle-Branch Block; Child; Child, Preschool; Electrocardiography; Heart; Humans; Infant; Infant, Newborn; Long QT Syndrome; Membrane Potentials; Nadolol; Propranolol; Reference Values | 1994 |
Electrophysiological analysis of effect of propranolol in rabbit S2 proximal straight tubule.
Topics: Animals; Barium; Dose-Response Relationship, Drug; Electrophysiology; Kidney Tubules, Proximal; Membrane Potentials; Monosaccharide Transport Proteins; Nadolol; Potassium; Potassium Channels; Propranolol; Rabbits; Sodium-Hydrogen Exchangers | 1994 |
Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field.
Topics: Adrenergic beta-Antagonists; Animals; Body Temperature; Injections, Intraperitoneal; Injections, Intraventricular; Interleukin-6; Male; Nadolol; Propranolol; Rats; Rats, Sprague-Dawley; Stereoisomerism; Stress, Psychological | 1996 |
Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Animals; Azides; Benzodiazepines; Carbolines; Catecholamines; Corticosterone; Diazepam; Disease Models, Animal; Female; GABA-A Receptor Agonists; Glucocorticoids; Immunity, Cellular; Immunity, Innate; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mifepristone; Nadolol; Naltrexone; Neurosecretory Systems; Oxidopamine; Phentolamine; Picrotoxin; Propranolol; Receptors, GABA-A; Spleen; Sympathetic Nervous System | 1996 |
Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Male; Mesentery; Methoxamine; Nadolol; Norepinephrine; Perfusion; Propranolol; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1996 |
The influence of endogenous catecholamines on the inhibitory effects of rolipram against early- and late-phase response to antigen in the guinea pig.
Topics: Adrenalectomy; Animals; Antigens; Catecholamines; Cimetidine; Guinea Pigs; Indomethacin; Male; Nadolol; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rolipram | 1997 |
Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration.
Topics: Animals; Atropine Derivatives; Autonomic Nervous System; Blood Pressure; Chlorisondamine; Heart Rate; Immunosuppressive Agents; Lymphocyte Activation; Male; Mice; Morphine; Nadolol; Neuropeptides; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley | 1996 |
Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Benzofurans; Betaxolol; Brimonidine Tartrate; Cocaine; Discrimination Learning; Discrimination, Psychological; Drug Synergism; Imidazoles; Male; Nadolol; Narcotics; Propanolamines; Propranolol; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Thiophenes | 1997 |
The effects of beta-adrenoceptor antagonists on a rat model of neuroleptic-induced akathisia.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Arousal; Catalepsy; Defecation; Emotions; Haloperidol; Male; Metoprolol; Motor Activity; Nadolol; Propranolol; Rats; Rats, Wistar; Reaction Time | 1997 |
In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood-Brain Barrier; Cytotoxicity, Immunologic; Immunity, Innate; Injections, Subcutaneous; Killer Cells, Natural; Leukocyte Count; Lung Neoplasms; Lymphocyte Count; Lymphocyte Depletion; Male; Mammary Neoplasms, Experimental; Metaproterenol; Nadolol; Propranolol; Rats; Rats, Inbred F344; Time Factors; Tumor Cells, Cultured | 1998 |
Study of propranolol and its related adrenoceptor antagonists on changes of gastric electrical parameters induced by ethanol in rats.
Topics: Adrenergic beta-Antagonists; Animals; Butoxamine; Dose-Response Relationship, Drug; Electric Conductivity; Electrophysiology; Ethanol; Gastric Mucosa; Labetalol; Male; Metoprolol; Nadolol; Propranolol; Rats; Rats, Sprague-Dawley | 1999 |
Increased brain serotonin synthesis in migraine.
Topics: Adrenergic beta-Antagonists; Adult; Brain; Female; Humans; Middle Aged; Migraine Disorders; Nadolol; Propranolol; Radionuclide Imaging; Reference Values; Serotonin | 1999 |
Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Child, Preschool; Cohort Studies; Death, Sudden; Electric Countershock; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Middle Aged; Nadolol; Pacemaker, Artificial; Prognosis; Propranolol; Risk Assessment; Survival Analysis; Treatment Outcome | 1999 |
Beta-blocker plus nitrate for primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Nadolol; Portal System; Propranolol | 2000 |
Ion-exchange fibers and drugs: an equilibrium study.
Topics: Calcium; Drug Delivery Systems; Ion Exchange; Nadolol; Osmolar Concentration; Propranolol; Solubility; Tacrine | 2001 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Hypertension and the kidney: implications of the kidney for effective antihypertensive therapy
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Hypertension; Kidney; Nadolol; Propranolol; Renal Circulation; Vasodilator Agents | 1987 |
Binding and release of drugs into and from thermosensitive poly(N-vinyl caprolactam) nanoparticles.
Topics: Adrenergic beta-Antagonists; Caprolactam; Chemical Phenomena; Chemistry, Physical; Cholinesterase Inhibitors; Hydrogels; Kinetics; Light; Nadolol; Nanotechnology; Particle Size; Polymers; Propranolol; Scattering, Radiation; Tacrine; Temperature; Water | 2002 |
Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Caco-2 Cells; Cell Survival; Cyclodextrins; Dextrans; Excipients; Fluorescein-5-isothiocyanate; Humans; Intestinal Absorption; Nadolol; Permeability; Polyethylene Glycols; Polysorbates; Propranolol; Propylene Glycol; Solubility; Solvents | 2002 |
Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent.
Topics: Adrenergic beta-Antagonists; Metoprolol; Mississippi; Nadolol; New York; Propranolol; Texas; Waste Disposal, Fluid; Water Pollutants, Chemical | 2003 |
Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Alzheimer Disease; Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Maze Learning; Muscarinic Antagonists; Nadolol; Propranolol; Psychomotor Performance; Rats; Rats, Long-Evans; Scopolamine; Spatial Behavior; Time Factors | 2003 |
The use of multi-frequency EPR techniques to identify the radicals produced in irradiated beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Electron Spin Resonance Spectroscopy; Free Radicals; Nadolol; Propanolamines; Propranolol; Temperature | 2004 |
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
Topics: Adrenergic beta-Antagonists; Brain Edema; Catecholamines; Child; Decerebrate State; Electrocardiography; Emergencies; Female; Humans; Infusions, Intravenous; Intensive Care Units, Pediatric; Nadolol; Propranolol; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Ultrasonography | 2004 |
Management of cirrhosis and ascites.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2004 |
Beta-blocker goes on trial as asthma therapy.
Topics: Animals; Asthma; Clinical Trials as Topic; Contraindications; Humans; Nadolol; Propranolol; Time Factors; United States; United States Food and Drug Administration | 2004 |
G-protein-coupled receptor chromatographic stationary phases. 2. Ligand-induced conformational mobility in an immobilized beta2-adrenergic receptor.
Topics: Adrenergic beta-Antagonists; Animals; Binding Sites; Butoxamine; Cell Line; Chromatography, Affinity; Ligands; Membrane Proteins; Mice; Nadolol; Propanolamines; Propranolol; Protein Conformation; Receptors, Adrenergic; Receptors, G-Protein-Coupled; Time Factors | 2004 |
[Correlation between absorption rates of beta-adrenoreceptor antagonists in rat small intestine and their molecular structures].
Topics: Adrenergic beta-Antagonists; Animals; Intestinal Absorption; Intestine, Small; Metoprolol; Molecular Structure; Nadolol; Propranolol; Rats; Regression Analysis | 2005 |
Development of an on-line extraction turbulent flow chromatography tandem mass spectrometry method for cassette analysis of Caco-2 cell based bi-directional assay samples.
Topics: Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Dexamethasone; Etoposide; Furosemide; Humans; Metoprolol; Nadolol; Pharmaceutical Preparations; Propranolol; Quinidine; Rhodamine 123; Spectrometry, Mass, Electrospray Ionization; Sulfasalazine; Verapamil | 2006 |
Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway.
Topics: Cytoplasmic Granules; Dose-Response Relationship, Drug; Humans; Nadolol; Phosphatidate Phosphatase; Phosphatidic Acids; Phospholipase D; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Propranolol; Protein Kinase C; rap1 GTP-Binding Proteins; Receptor, PAR-1; Receptors, Thrombin | 2007 |
Central but not peripheral beta-adrenergic antagonism blocks reconsolidation for a morphine place preference.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Drug Administration Routes; Male; Memory; Morphine; Nadolol; Narcotics; Propranolol; Rats; Rats, Long-Evans | 2007 |
Adsorption of beta blockers to environmental surfaces.
Topics: Adrenergic beta-Antagonists; Adsorption; Benzenesulfonates; Confidence Intervals; Environment; Hydrogen-Ion Concentration; Metoprolol; Minerals; Nadolol; Propranolol; Rivers; Surface Properties; Surface-Active Agents | 2007 |
Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Brain; Cytokines; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Inflammation Mediators; Interleukin-1; Isoproterenol; Male; Microinjections; Nadolol; Propranolol; Rats; Rats, Inbred F344; Receptors, Adrenergic, beta | 2008 |
Determination of selected beta-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS.
Topics: Acebutolol; Animals; Cholesterol; Chromatography, High Pressure Liquid; Humans; Male; Mice; Nadolol; Oxprenolol; Propanolamines; Propranolol; Reproducibility of Results; Silicon Dioxide; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Surface Properties | 2009 |
Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Benzodiazepines; Chlordiazepoxide; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Injections, Intraperitoneal; Interleukin-10; Interleukins; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Nadolol; Norepinephrine; Propranolol; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Stress, Psychological | 2009 |
Central beta-adrenergic receptors play an important role in the enhancing effect of voluntary exercise on learning and memory in rat.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System; Male; Maze Learning; Memory; Nadolol; Physical Conditioning, Animal; Propranolol; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Space Perception | 2010 |
Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.
Topics: Adrenergic beta-Antagonists; Adult; Brain; Brain Mapping; Child; Child Development Disorders, Pervasive; Decision Making; Female; Humans; Language Tests; Magnetic Resonance Imaging; Male; Nadolol; Neural Pathways; Neuropsychological Tests; Phonetics; Pilot Projects; Propranolol; Young Adult | 2010 |
Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats.
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Alcoholism; Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Male; Nadolol; Norepinephrine; Propranolol; Rats; Rats, Wistar; Reinforcement Schedule; Reward; Self Administration; Substance Withdrawal Syndrome; Time Factors | 2010 |
A specialized, nurse-run titration clinic: a feasible option for optimizing beta-blockade in non-clinical trial patients.
Topics: Adrenergic beta-Antagonists; Ambulatory Care Facilities; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Practice Patterns, Nurses'; Propranolol; Prospective Studies; Treatment Outcome | 2010 |
Response to salbutamol in patients with mild asthma treated with nadolol.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Asthma; Female; Humans; Male; Middle Aged; Nadolol; Propranolol; Respiratory Function Tests; Treatment Outcome | 2010 |
Matrix-assisted laser desorption/ionization mass spectrometry for quantitative determination of β-blocker drugs in one-drop of human serum sample.
Topics: Adrenergic beta-Antagonists; Chemical Fractionation; Humans; Hydrogen-Ion Concentration; Hypertension; Linear Models; Nadolol; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Sodium Chloride; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Toluene | 2011 |
Early post-stressor intervention with propranolol is ineffective in preventing posttraumatic stress responses in an animal model for PTSD.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Behavior, Animal; Cues; Disease Models, Animal; Heart Rate; Injections, Subcutaneous; Male; Maze Learning; Memory; Memory, Long-Term; Nadolol; Propranolol; Rats; Rats, Sprague-Dawley; Reflex, Startle; Stress Disorders, Post-Traumatic; Stress, Psychological; Time Factors; Treatment Outcome | 2011 |
Evening administration of long-acting beta-blockers for primary prophylaxis in cirrhosis: an effective strategy.
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Drug Administration Schedule; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Treatment Outcome | 2011 |
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Long QT Syndrome; Nadolol; Propranolol | 2011 |
Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
Topics: Adrenergic beta-Antagonists; Cell Line; Humans; Long QT Syndrome; Metoprolol; Mutation; Nadolol; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Propranolol; Sodium Channel Blockers; Sodium Channels | 2012 |
Fear conditioning can contribute to behavioral changes observed in a repeated stress model.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Conditioning, Psychological; Corticosterone; Disease Models, Animal; Environment; Exploratory Behavior; Fear; Food Preferences; Glucocorticoids; Interpersonal Relations; Nadolol; Propranolol; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Stress, Psychological; Sucrose | 2012 |
Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Nadolol; Propranolol; Treatment Outcome | 2013 |
A prospective, 1-year follow-up study of postural tachycardia syndrome.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Atenolol; Cholinesterase Inhibitors; Female; Fludrocortisone; Follow-Up Studies; Heart Rate; Humans; Male; Metoprolol; Midodrine; Nadolol; Norepinephrine; Postural Orthostatic Tachycardia Syndrome; Propranolol; Prospective Studies; Pyridostigmine Bromide; Severity of Illness Index; Sodium; Tilt-Table Test; Virus Diseases | 2012 |
Novel insights into beta-blocker therapy for long QT syndromes.
Topics: Adrenergic beta-Antagonists; Female; Humans; Long QT Syndrome; Male; Metoprolol; Nadolol; Propranolol | 2012 |
Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Child; Disease-Free Survival; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Metoprolol; Nadolol; Prognosis; Propranolol; Secondary Prevention; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Cardiac; Female; Genotype; Heart Arrest; Humans; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Multivariate Analysis; Nadolol; Proportional Hazards Models; Propranolol; Registries; Regression Analysis; Risk Factors; Syncope; Time Factors; Treatment Outcome; Young Adult | 2014 |
Nadolol for the treatment of infantile hemangioma.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Child, Preschool; Female; Heart Rate; Hemangioma; Humans; Infant; Nadolol; Propranolol; Skin Neoplasms; Treatment Outcome | 2015 |
Frequency and severity of hypoglycemia in children with beta-blocker-treated long QT syndrome.
Topics: Adrenergic beta-Antagonists; Blood Glucose; Child; Child, Preschool; Female; Humans; Hypoglycemia; Infant; Ketosis; Long QT Syndrome; Male; Nadolol; Propranolol; Retrospective Studies; Treatment Outcome | 2015 |
β-Blockers have differential effects on the murine asthma phenotype.
Topics: Adrenergic beta-Antagonists; Allergens; Alprenolol; Animals; Asthma; Bronchoalveolar Lavage Fluid; Carbazoles; Carvedilol; Cell Count; Epinephrine; Female; Male; Mice, Knockout; Models, Biological; Mucins; Nadolol; Ovalbumin; Phenotype; Propanolamines; Propranolol | 2015 |
Bidirectional Modulation of Alcohol-Associated Memory Reconsolidation through Manipulation of Adrenergic Signaling.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Conditioning, Classical; Cues; Drug-Seeking Behavior; Epinephrine; Ethanol; Male; Memory Consolidation; Nadolol; Propranolol; Rats; Receptors, Adrenergic, beta; Reinforcement, Psychology; Self Administration | 2016 |
Role of β-Adrenoceptors and L-Type Ca(2+)-Channels in the Mechanism of Reperfusion-Induced Heart Injury.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Channels, L-Type; Male; Myocardial Reperfusion Injury; Myocardium; Nadolol; Propranolol; Rats; Receptors, Adrenergic, beta; Verapamil | 2016 |
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Ascites; Cohort Studies; Comorbidity; Dose-Response Relationship, Drug; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Primary Prevention; Proportional Hazards Models; Propranolol; Retrospective Studies; Risk Assessment; Risk Factors; United States; United States Department of Veterans Affairs | 2016 |
Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Autism Spectrum Disorder; Brain; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Nadolol; Neural Pathways; Propranolol; Receptors, Adrenergic, beta; Rest; Young Adult | 2017 |
Discrete β-adrenergic mechanisms regulate early and late erythropoiesis in erythropoietin-resistant anemia.
Topics: Adrenergic Antagonists; Anemia; Animals; Burns; Butoxamine; Disease Models, Animal; Erythropoiesis; Male; Mice; Nadolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2017 |
Primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propanolamines; Propranolol | 2018 |
Disrupting reconsolidation: memory erasure or blunting of emotional/motivational value?
Topics: Adrenergic beta-Antagonists; Animals; Conditioning, Classical; Cues; Emotions; Male; Memory Consolidation; Motivation; Nadolol; Propranolol; Rats; Rats, Sprague-Dawley; Reward | 2019 |
Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats.
Topics: Adrenergic beta-Antagonists; Animals; Male; Maze Learning; Nadolol; Neuroprotective Agents; Propranolol; Random Allocation; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Social Defeat; Social Interaction; Stress, Psychological | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
Propranolol versus nadolol for treatment of pediatric subglottic hemangioma.
Topics: Adrenergic beta-Antagonists; Child; Female; Hemangioma; Humans; Infant; Male; Nadolol; Propranolol; Retrospective Studies; Treatment Outcome | 2021 |